Lilly to invest $450m to expand its Research Triangle Park facility in US
The US drugmaker intends to start initial production from the expanded Research Triangle Park this year, with full…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 Jan 23
The US drugmaker intends to start initial production from the expanded Research Triangle Park this year, with full…
05 Dec 22
The investment, which forms part of Pfizer’s strategy to expand manufacturing capacity in Europe, will focus on the…
06 Oct 22
The new Bio-CDMO facility, which is expected to commence operations in financial year 2026, will be capable of…
25 Aug 22
The new facility in Plainville, Massachusetts is intended to manufacture materials central to the production of gene-based therapeutics
31 May 22
The acquisition is expected to expand Evotec’s cell therapy platform EVOcells, an integrated platform for the discovery, development…
24 May 22
The investment will enhance the membrane manufacturing capacities, enables the construction of a new filtration manufacturing facility, and…
11 Apr 22
The recalled vaccines form the lot were supplied in Norway, Poland, Portugal, Spain and Sweden from 13 to…
06 Apr 22
The MAST platform provides real-time process information, reduces the process development time by half, and lowers costs
28 Mar 22
The new manufacturing facility at Kent Science Park is designed to support the manufacture of regulatory approved cannabis-based…
08 Mar 22
The new site will use new technologies to enhance the efficiency and capability to produce a wide range…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates